Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology
Published: February 24, 2025
- Given the significant heterogeneity in cardiovascular (CV) risk among cancer patients undergoing cancer therapy, there is a need to improve risk stratification by incorporating individualized patient, cancer, and therapy-related factors.
- This statement examines how artificial intelligence (AI) can be utilized to enhance risk prediction models, advancing the field toward precision medicine.
- The implementation of AI in precision medicine for cardio-oncology poses challenges regarding data security, privacy, potential biases, and ensuring diverse and equitable access. Thus, developing AI in this field will require careful oversight from key stakeholders, including clinicians, researchers, regulatory bodies, and reimbursement entities.
Video: Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology
Authors Tochukwu Okwuosa, DO, FAHA and Khera Rohan, MD, MS, FAHA announce the publication of the new scientific statement and discuss some of the ways AI can now be used to improve patient care.